Mitochondrial function in neuronal cells depends on p97/VCP/Cdc48-mediated quality control by Lei Fang et al.
ORIGINAL RESEARCH ARTICLE
published: 02 February 2015
doi: 10.3389/fncel.2015.00016
Mitochondrial function in neuronal cells depends on
p97/VCP/Cdc48-mediated quality control
Lei Fang1, Charles Hemion1, Ana C. Pinho Ferreira Bento1, Claudia C. Bippes1, Josef Flammer2 and
Albert Neutzner1,2*
1 Department of Biomedicine, University of Basel, Basel, Switzerland
2 Department of Ophthalmology, University of Basel, Basel, Switzerland
Edited by:
Lawrence Rajendran, University of
Zurich, Switzerland
Reviewed by:
Hariharasubramanian Ramakrishnan,
State University of New York, USA
Krishna Vadodaria, Salk Institute for
Biological Science, USA
*Correspondence:
Albert Neutzner, Department of
Biomedicine and Department of
Ophthalmology, University of Basel,
Hebelstrasse 20, 4031 Basel,
Switzerland
e-mail: albert.neutzner@unibas.ch
Maintaining mitochondrial function is essential for neuronal survival and offers
protection against neurodegeneration. Ubiquitin-mediated, proteasome-dependent
protein degradation in the form of outer mitochondrial membrane associated degradation
(OMMAD) was shown to play roles in maintenance of mitochondria on the level
of proteostasis, but also mitophagy and cell death. Recently, the AAA-ATPase
p97/VCP/Cdc48 was recognized as part of OMMAD acting as retrotranslocase of
ubiquitinated mitochondrial proteins for proteasomal degradation. Thus, p97 likely plays a
major role in mitochondrial maintenance. Support for this notion comes frommitochondrial
dysfunction associated with amyotrophic lateral sclerosis and hereditary inclusion body
myopathy associated with Paget disease of bone and frontotemporal dementia (IBMPFD)
caused by p97 mutation. Using SH-SY5Y cells stably expressing p97 or dominant-negative
p97QQ treated with mitochondrial toxins rotenone, 6-OHDA, or Aβ-peptide as model
for neuronal cells suffering from mitochondrial dysfunction, we found mitochondrial
fragmentation under normal and stress conditions was significantly increased upon
inactivation of p97. Furthermore, inactivation of p97 resulted in loss of mitochondrial
membrane potential and increased production of reactive oxygen species (ROS). Under
additional stress conditions, loss of mitochondrial membrane potential and increased ROS
production was even more pronounced. Loss of mitochondrial fidelity upon inactivation
of p97 was likely due to disturbed maintenance of mitochondrial proteostasis as the
employed treatments neither induced mitophagy nor cell death. This was supported by
the accumulation of oxidatively-damaged proteins on mitochondria in response to p97
inactivation. Dysfunction of p97 under normal and stress conditions in neuron-like cells
severely impacts mitochondrial function, thus supporting for the first time a role for p97
as a major component of mitochondrial proteostasis.
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INTRODUCTION
Failing mitochondrial maintenance is at the heart of neurodegen-
eration and associated neuronal death (Karbowski and Neutzner,
2012; Kornmann, 2014). To prevent the untimely death of
neuronal cells, mitochondria are kept healthy and in shape
through the complex interplay of various molecular mecha-
nisms aimed at repairing mitochondrial damage on themolecular
level (Anand et al., 2013) or at removing damaged mitochon-
drial subunits from the cell (Youle and Narendra, 2011). A
key component of mitochondrial maintenance is quality con-
trol of damaged, dysfunctional proteins through protein degra-
dation (Neutzner et al., 2008; Escobar-Henriques and Langer,
2014). Owed to the complex architecture and the endosymbiotic
nature of mitochondria, several protein degradation mechanisms
are in place to maintain proteostasis in the various mitochon-
drial compartments (Tatsuta and Langer, 2008). Recently, we
and others described roles for the ubiquitin-proteasome sys-
tem in maintaining mitochondrial function and proteostatis.
E3 enzymes, namely MARCH5/MITOL (Karbowski et al., 2007;
Nagashima et al., 2014), MAPL/MULAN (Braschi et al., 2009),
IBRDC2 (Benard et al., 2010), RNF185 (Tang et al., 2011),
and Parkin (Narendra et al., 2008) were found to localize to
the mitochondrial outer membrane. Furthermore, ubiquitin-
dependent protein degradation was shown to modulate mito-
chondrial morphology (Neutzner and Youle, 2005; Karbowski
et al., 2007; Cohen et al., 2008; Leboucher et al., 2012) and
impact mitophagy (Narendra et al., 2012). In addition, quality
control of mitochondria-localized poly-Q (Sugiura et al., 2011),
amyotrophic lateral sclerosis associated mSOD1 as well as S-
nitrosylated proteins (Benischke et al., 2014) is performed by
the ubiquitin-proteasome system. Analogous to the endoplas-
mic reticulum (ER) which is quality controlled by ER associated
degradation or ERAD (Ruggiano et al., 2014), mitochondria
might be considered to be under control of outer mitochondrial
membrane associated degradation (OMMAD, Neutzner et al.,
2007).
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Quality control of proteins localized to a membrane-bound
organelle by the cytosolic ubiquitin-proteasome system must
involve the protein extraction from the organelle and retro-
translocation into the cytosol for degradation. The AAA-ATPase
valosin containing protein VCP/p97/Cdc48 is the central com-
ponent of this retrotranslocation machinery necessary for pro-
teasomal degradation of organellar proteins (Meyer et al., 2012).
Interestingly, p97 fulfils this function for ERAD (Wolf and Stolz,
2012) andOMMAD (Xu et al., 2011) alike. As such, p97 is an inte-
gral part of proteasomal quality control of ER-localized as well
as mitochondrial proteins. While the role of p97 in maintaining
ER proteostasis is extensively studied, the connection between p97
and mitochondrial health is less clear. However, p97 dysfunction
was recently linked to some forms of amyotrophic lateral sclero-
sis and hereditary inclusion body myopathy associated with Paget
disease of bone and frontotemporal dementia (IBMPFD) and a
connection to failed mitochondrial quality control was suspected
(Yamanaka et al., 2012).
To further define the role of p97 in mitochondrial main-
tenance especially in neuronal-like cells, we studied the influ-
ence of p97 inactivation on mitochondrial health and function
in SH-SY5Y cells in comparison to known neurotoxic mito-
chondrial insults. We found that inactivation of p97 negatively
impacts mitochondrial function in terms of membrane poten-
tial, reactive oxygen production, morphological changes, and
accumulation of oxidized proteins comparably to treatment with
the electron transport chain inhibitor rotenone, the neurotoxin
6-hydroxydopamine as well as Alzheimer’s disease related Aβ
peptide. These findings support an important function for p97
in maintaining neuronal health through mitochondrial pro-
tein quality control and further strengthen the link between
mitochondrial dysfunction and premature neuronal death.
RESULTS
MITOCHONDRIAL FRAGMENTATION AS RESULT OF INACTIVATION
OF p97
Mitochondria fragment in response to mitochondrial insults such
as the complex I inhibitor rotenone, the neurotoxic compound 6-
hydroxydopamine (6-OHDA) or the Alzheimer’s-related peptide
Aβ. To assess whether p97 is involved in mitochondrial mainte-
nance and stress protection in neuron-like cells, p97 function was
blocked by overexpression of p97QQ, a dominant-negative ver-
sion of p97, under conditions of mitochondrial insult. In order
to induce low level mitochondrial insult, toxin concentration and
time of insult was selected to minimize impact on cellular viabil-
ity. To this end, SH-SY5Y neuroblastoma cells stably expressing
p97 or dominant-negative p97QQ under control of a tetracycline-
inducible promoter were treated with tetracycline in the presence
of rotenone, 6-OHDA, or Aβ. As shown in Figure 1, expres-
sion of p97QQ caused mitochondrial fragmentation in 57.3 ±
5.9% compared to 5 ± 2% in control cells expressing p97 and
7 ± 1% in uninduced p97QQ cells. Treatment of p97-expressing
cells with the mitochondrial toxins rotenone, 6-OHDA or Aβ
resulted in mitochondrial fragmentation in 59.3 ± 7.6%, 69 ±
6.2%, and 53.3 ± 6.7%, respectively. Interestingly, expression of
p97QQ in the presence of mitochondrial toxins had a strong addi-
tive effect and caused mitochondrial fragmentation in 92.3 ±
3.1% (rotenone), 95 ± 1.7% (6-OHDA), and 96.7 ± 2.5% (Aβ)
of SH-SY5Y cells. These data are consistent with a role for p97
in mitochondrial maintenance during normal as well as under
mitochondrial stress conditions. To further explore this func-
tion of p97 on mitochondria in neuron-like cells, highly purified
mitochondria were analyzed by western blotting for the presence
of p97. As shown in Figure 1C, p97 was found in mitochon-
drial fractions from SH-SY5Y cells enriched in the mitochondrial
marker cytochrome c, but devoid of the ER-marker calnexin.
These data are consistent with p97 present on mitochondria and
confirm previous observations of mitochondrial p97 (Xu et al.,
2011).
INACTIVATION OF p97 NEGATIVELY IMPACTS MITOCHONDRIAL
MEMBRANE POTENTIAL AND INCREASES PRODUCTION OF REACTIVE
OXYGEN SPECIES
Mitochondrial membrane potential is a measure for mitochon-
drial health with a drop in membrane potential being a sign of
mitochondrial dysfunction. Mitochondrial membrane potential
was measured in neuron-like cells under conditions of mitochon-
drial insult during p97 inactivation to further assess the role of
p97 in maintaining mitochondrial health. To this end, SH-SY5Y
cells stably expressing p97 or p97QQ were treated with rotenone,
6-OHDA, or Aβ or left untreated as control and mitochon-
drial membrane potential was measured using the membrane-
potential sensitive dye tetramethylrhodamine ethyl ester (TMRE).
As shown in Figure 2A, ectopic expression of p97 did not impact
mitochondrial membrane potential compared to control, while
the potential was diminished to 80.6 ± 6.0% of control by
expression of p97QQ. Furthermore, treatment with mitochon-
drial toxins in addition to p97QQ expression caused a further
reduction of mitochondrial membrane potential to 60.9 ± 8.3%
(rotenone), 61.5 ± 4.6% (6-OHDA), and 62.9 ± 5.6% (Aβ).
Pharmacological inhibition of p97 was employed to confirm the
observed impact of p97 inactivation on mitochondrial mem-
brane potential. To this end, SH-SY5Y cells were treated with
the specific p97 inhibitor DBeQ or vehicle (DMSO) and flow
cytometric analysis of TMRE fluorescence was performed. As
shown in Figure 2B, DBeQ-dependent inhibition of p97 caused
a reduction of TMRE fluorescence to 74.7 ± 11.5 of control cells
(p = 0.072) comparable to the drop of mitochondrial membrane
potential following expression of p97QQ.
In addition to mitochondrial depolarization, increased pro-
duction of reactive oxygen species (ROS) is a hallmark of failing
mitochondrial maintenance and subsequent dysfunction. To fur-
ther analyse the role of p97 in mitochondrial maintenance in
neuron-like cells cells, ROS production was measured under
mitochondrial stress conditions in the presence or absence of p97
function. Again, SH-SY5Y cells stably containing tetracycline-
inducible p97 or p97QQ were induced with tetracycline, treated
with rotenone, 6-OHDA, or Aβ or left untreated as control,
and mitochondrial ROS levels were analyzed by flow cytometry
using the ROS-sensitive dye MitoSox. While ectopic expression of
p97 had only a minor influence on ROS levels (114.9 ± 8.7%)
compared to uninduced control cells (Figure 2C), expression of
p97QQ alone caused ROS levels to increase to 212.7 ± 18.7%.
Additional treatment of p97 expressing cells with mitochondrial
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FIGURE 1 | Inactivation of p97 increased mitochondrial fragmentation
under stress. (A) SH-SY5Y cells stably expressing p97 or
dominant-negative p97QQ under control of the Tet-On promoter were
induced with tetracycline for 16 h or left uninduced and treated with 5μM
rotenone, 75μM 6 OHDA, or 50μM Aβ for 6 h. Cells were fixed and
stained using anti-cytochrome c antibody and Alexa546-conjugated
secondary antibody. Shown are representative pictures from three
independent experiments. (B) Fragmentation of the mitochondrial network
in cells from (A) was quantified by visual examination. Shown is the
average of three independent experiments. Statistical analysis was
performed using pair-wise t-tests with p-value adjustment according to
Holm. Statistical significance is marked with n.s. for not significant,
∗∗∗p < 0.001. (C) The presence of p97 on mitochondria was analyzed by
western blotting using anti-p97 antibodies following purification of
mitochondria using anti-TOMM22 magnetic beads. The purity of
mitochondrial fractions was assessed by detecting the ER marker calnexin
and the mitochondrial marker cytochrome c (cyt. c). Shown is one
representative out of three independent experiments.
toxins further increased ROS levels to 158 ± 8.3% (rotenone),
167.7 ± 9% (6-OHDA), and 294.3 ± 14.1% (Aβ). In response
to p97 inactivation under mitochondrial stress conditions ROS
levels further increased to 290.4 ± 55.6% (rotenone), 360.9 ±
58.9% (6-OHDA), and 611.5 ± 129.1% (Aβ). As above, phar-
macological inhibition was used to confirm the impact of p97
on mitochondrial ROS production (Figure 2D). Treatment with
the p97 inhibitor DBeQ caused a highly significant 1.8 ± 0.2 fold
increase in ROS production compared to vehicle treated control
cells again confirming the observed elevated ROS levels following
expression of p97QQ. The observed increase of ROS produc-
tion following p97 inactivation and the significant additive effect
on ROS production of inactive p97 during mitochondrial stress
strongly support a crucial role for p97-dependent mitochondrial
maintenance under normal as well as stress conditions.
INACTIVATION OF p97 IMPAIRS MITOCHONDRIAL MAINTENANCE
BELOW THE MITOPHAGIC THRESHOLD
Recently, p97 was implicated in the execution of mitophagy
(Tanaka et al., 2010). To assess whether the observed mito-
chondrial dysfunction under the employed stress conditions and
p97 inactivation are linked to blocked mitophagy or might be
attributed to other roles of p97, Parkin translocation to mito-
chondria (Narendra et al., 2008) as a marker for mitophagic
induction was measured. To this end, SH-SY5Y cells stably
expressing p97 or p97QQ were transfected with an expres-
sion construct for YFP-tagged Parkin, induced with tetracy-
cline and exposed to mitochondrial insults by treating with
rotenone, 6-OHDA, or Aβ. Treatment with the protonophore
(3-Chlorophenyl)hydrazonomalononitrile (CCCP) capable of
complete mitochondrial depolarization and subsequent Parkin
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FIGURE 2 | Inactivation of p97 impairs mitochondrial function during
neurotoxic stress. (A) SH-SY5Y cells stably expressing p97 or
dominant-negative p97QQ under control of the Tet-On promoter were
induced with tetracycline for 2 h or left uninduced and treated with
5μM rotenone, 75μM 6 OHDA, or 50μM Aβ for an additional 6 h.
Cells were stained with the mitochondrial membrane sensitive dye
TMRE and analyzed by flow cytometry. (B) SH-SY5Y cells were
treated with the p97 inhibitor DBeQ and mitochondrial membrane
potential was measured by flow cytometric analysis of TMRE
fluorescence. (C) Cells treated as in (A) were stained with the
ROS-sensitive dye MitoSox and mitochondrial ROS generation was
measured using flow cytometry. (D) SH-SY5Y cells were treated with
the p97 inhibitor DBeQ and mitochondrial ROS generation was
measured by flow cytometric analysis of MitoSox fluorescence.
Statistical analysis was performed using pair-wise t-tests with Holm
p-value adjustment for (A,C), and a general linear model (SPSS) for
(B,D). Statistical significance is marked with n.s. for not significant,
#p < 0.1, ∗∗p < 0.01, ∗∗∗p < 0.001.
translocation served as control. As shown in Figures 3A,B, while
treatment with CCCP induced Parkin translocation in almost
all cells, neither expression of p97 or p97QQ, nor neurotoxin
treatment at the used concentrations caused significant (<4%)
translocation of Parkin to mitochondria. Consistent with this
finding, the employed concentrations of rotenone, 6-OHDA,
and Aβ also did not lead to cell death as measured by flow
cytometry (Figure 3C), neither in the presence of ectopic p97
nor following expression of p97QQ. Thus, while the employed
treatments with neurotoxic substances degraded mitochondrial
function, the threshold for mitophagic induction as well as cell
death was not reached. Therefore, the observed role for p97 in
mitochondrial maintenance under the stress conditions employed
by us is also likely on the protein degradation level rather than on
the mitophagic or cell death level.
p97 IS INVOLVED IN CLEARING OXIDATIVELY-DAMAGED PROTEINS
FROMMITOCHONDRIA
To further support this notion, the ubiquitin- and p97-mediated
proteasome-dependent turnover of oxidized mitochondrial pro-
teins under mitochondrial stress conditions was measured. In
SH-SY5Y cells ectopically expressing p97, treatment with neither
rotenone, nor 6-OHDA or Aβ significantly increased levels of
oxidized proteins compared to untreated control cells (Figure 4,
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FIGURE 3 | p97 is involved in mitochondrial maintenance at damage
levels below the thresholds for mitophagy and cell death. (A) SH-SY5Y
cells stably expressing p97 or dominant-negative p97QQ under control of the
Tet-On promoter were transfected with an expression construct for
YFP-tagged Parkin, induced with tetracycline for 2 h or left uninduced and
treated with 5μM rotenone, 75μM 6 OHDA, or 50μM Aβ for an additional
6 h. Cells were fixed, stained for the mitochondrial marker cytochrome c (cyt.
c) and Parkin translocation from the cytosol to mitochondria was visually
analyzed using fluorescence microscopy. Shown are representative images
of three independent experiments. (B) Shown is a quantification of Parkin
translocation from the cytosol to mitochondria from (A). (C) Cells treated as in
(A) were stained with the cell impermeable dye 4′,6-diamidino-2-phenylindole
(DAPI) and the percentage of dead cells was determined by flow cytometry.
Statistical analysis was performed using pair-wise t-tests with p-value
adjustment according to Holm. Statistical significance is marked with
∗∗∗p < 0.001. In (C) no statistical significance was observed.
for representative western blots see Supplementary Figure S1).
Interestingly, in p97QQ expressing cells, levels of oxidized mito-
chondrial proteins were significantly increased (p < 0.001) com-
pared to p97 expressing cells confirming a function for p97
in the removal of oxidatively-damaged mitochondrial proteins.
Furthermore, levels of oxidized proteins significantly increased
in p97QQ expressing cells under mitochondrial stress conditions
due to rotenone, 6-OHDA, and Aβ treatment compared to p97QQ
control cells. Again, these data are consistent with the involvement
of p97 in the degradation of damaged proteins to maintain
mitochondrial function in neuron-like cells under mitochondrial
stress conditions below the threshold of mitophagic induction or
cell death.
DISCUSSION
Mechanisms of mitochondrial maintenance act on the cellular
level by removing complete dysfunctional mitochondrial net-
works through programmed cell death. On the organellar level
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FIGURE 4 | Clearance of oxidatively-damaged mitochondrial proteins is
impaired following inactivation of p97. SH-SY5Y cells stably expressing
p97 or dominant-negative p97QQ under control of the Tet-On promoter
were induced with tetracycline for 2 h or left uninduced and treated with
5μM rotenone, 75μM 6 OHDA, or 50μM Aβ for an additional 6 h.
Mitochondria were isolated using anti-TOMM22 magnetic beads resulting
in highly purified mitochondria. Protein carbonylation as measure for
oxidative damage was determined by infrared laser-based quantitative
western blotting following derivatization with 2,4-Dinitrophenylhydrazine
(DNPH) and detection using anti-DNP antibodies. Shown is the average of
three independent experiments. Please see Supplementary Figure S1 for
representative western blot images. Statistical analysis was performed
using pair-wise t-tests with p-value adjustment according to Holm.
Comparisons shown are tetracycline-induced, untreated cells vs.
tetracycline-induced, treated cells. Statistical significance is marked with
n.s. for not significant, ∗∗∗p < 0.001.
they act through mitophagic degradation of dysfunctional mito-
chondrial subunits and finally on the molecular level by repairing
and/or removing damaged mitochondrial components such as
DNA, lipids or proteins (Tatsuta and Langer, 2008). While pro-
grammed cell death is an effective means to rid the body of
damaged and, due to their excessive ROS production, poten-
tially harmful mitochondrial networks, in post-mitotic neurons
excessive apoptotic cell death is equivalent to neurodegeneration
(Radi et al., 2014). Thus, mitophagy and degradation of damaged
proteins are likely the first lines of defense against mitochon-
drial dysfunction in neurons as neuronal death is avoided. Which
mechanism, mitophagy or protein degradation is more prevalent
in neurons under normal conditions remains unclear. However,
it is conceivable that the removal of individual components such
as damaged proteins from otherwise functional mitochondria
might be preferable to the destruction of whole mitochondrial
subunits. Especially under conditions of everyday stress, with
slowly accumulating, low overall mitochondrial damage, keeping
mitochondrial damage below the mitophagic threshold through
the constant removal of damaged proteins is likely to prevent
neuronal damage.
Using known mitochondrial toxins such as rotenone, 6-
OHDA, and Aβ at concentrations and treatment times below the
threshold of cell death and mitophagic induction, we intended
to model the above mentioned low level stress and evaluate
the importance of p97 and associated protein degradation
as well as its influence on mitochondrial fidelity in neuronal
cells. Interestingly, inactivation of p97 alone—without addi-
tional exogenous stress–for as little as 8 h negatively influenced
mitochondrial morphology, membrane potential and ROS
production. Although p97 has many cellular functions and
pleiotropic effects of p97 inactivation have to be taken into
account, these observations are consistent with a direct role for
p97 in mitochondrial maintenance under normal conditions
in the absence of external mitochondrial stress. This notion is
further supported by the accumulation of oxidatively-damaged
mitochondrial proteins following p97 inactivation. Even under
normal conditions without exogenous mitochondrial stress, a
considerable amount of oxidized protein is present in mitochon-
dria and significantly accumulates as consequence of a short
period of p97 inactivation. Thus, in the absence of any detectable
mitophagic activity, continuous turnover of damaged mitochon-
drial proteins occurs in a p97-dependent manner. As p97 is an
ubiquitin-dependent chaperone, this is consistent with constantly
ongoing mitochondrial maintenance in neuronal cells through
the ubiquitin-proteasome system under normal, unstressed
conditions. Consistent with this finding, we also found p97 to
be present in mitochondrial fractions under normal conditions,
and recently we also connected p97 and oxidatively-damaged
proteins to OMMAD, the ubiquitin-dependent, proteasome-
mediated degradation mitochondrial proteins (Hemion et al.,
2014). Further support to this notion is lent by the effect of
p97 inactivation under exogenous stress conditions below the
mitophagic threshold. Concurrent stress and p97 inactivation
had additive effects on mitochondrial fragmentation, membrane
potential, ROS production as well as the accumulation of
oxidatively-damaged mitochondrial proteins. These observations
again support a function for p97 in dealing with mitochondrial
damage to keep dysfunction of mitochondria below the threshold
above which mitophagic degradation or even cell death occurs.
Thus, we propose that constant repair of mitochondrial damage
by the ubiquitin-proteasome system in a p97-dependent manner
even under conditions of no or low exogenous mitochondrial
stress is critically important for maintaining mitochondrial
function under normal conditions. Mitophagic clearance on the
other hand might be responsible for maintaining mitochondrial
function in response to more drastic insults likely not encoun-
tered under normal conditions. Taken together, p97-mediated
mitochondrial proteostasis is likely an important mechanism to
prevent mitochondrial dysfunction as result of slowly accruing
mitochondrial damage under normal conditions and to keep
associated neurodegenerative processes at bay.
MATERIALS AND METHODS
DNA CONSTRUCTS
To generate a vector for the one-step generation of stable,
tetracycline-inducible human cell lines, the CMV promoter in
the AAVS1 donor cloning vector DC-DON-SH01 (Genome-
TALER™ human AAVS1 safe harbor gene knock-in kit,
GeneCopoeia) was replaced by the hybrid CMV/Tet-On pro-
moter originating from pcDNA5/FRT/TO (Invitrogen) with
MluI/PmeI. Afterwards, a stuffer sequence with 5′ PmeI site
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followed by EcoRV site and 3′ BstBI site was inserted using PmeI,
BstBI to generate pAN2066. To enable tetracycline regulation of
the construct, the GFP coding region in pAN2066 was replaced
with the coding sequence of the tetracycline repressor. To this
end, the bGH poly-A-Ef1α-GFP fragment was amplified from
DC-DON-SH01 using ATTCGACTCGAGTTCGAATTTAA
ATCGGATCCCT and ATTCGAGATATCGATCCGGTGGAG
CCGGG and cloned into pBluescript SK (+) with XhoI/EcoRV to
create pAN2067. Next, GFP was replaced by TetR amplified using
PCR from pcDNA6/TR (Invitrogen) with ATTCGAAAGCTT
GTGAGTTTGGGGACCCTTG and ATTCGAGATATCGCAT
AAGATCTGAATTCCCGGGA and inserted HindIII/EcoRV
to generate pAN2070. Fragment bGH poly-A-Ef1α-TetR was
released from pAN2070 with BstBI/EcoRV and transferred to
pAN2066 cut with BstBI/NruI to obtain pAN2071. Then, p97 or
p97QQ (gift from S. Fang) was amplified by PCR using GACT
CGGATATCATGGCTTCTGGAGCCGATTCAA and TGTA
ACAACGTTTTAGCCATACAGGTCATCATCATCATT and
cloned EcoRV/BstBI into pAN2071.
Cell culture and generation of cell lines
SH-SY5Y cells were cultured in 5% CO2incubator at 37◦C in
high glucose DMEM (Sigma, D6546) containing 15% Tet System
Approved FBS (Clontech, 631106), supplemented with 2mM L-
glutamine (Sigma, G5713), and 1mM sodium pyruvate (Sigma,
G7513). To generate stably transfected SH-SY5Y cells express-
ing p97 or p97QQ under control of the Tet-On promoter, cells
were transfected using Effectene (Qiagen, 301425) according to
manufacturer’s recommendations with two TALEN constructs for
the PPP1R2C or AAVS1 “safe harbor” locus and an expression
construct containing p97 or p97QQ under control of the Tet-
On promoter as well as a puromycin resistance gene to enable
selection. For stably transfected cells, 0.75μg/ml puromycin was
added to maintain selection (Invivogen, ant-pr-1). Expression of
p97 or p97QQ was induced by treatment with 1μg/ml tetracycline
(Roth, Hp63.1). Mitochondrial stress was induced by treatment
with 5μM rotenone (Sigma, R8857), 75μM 6-hydroxdopamine
(Sigma, H8523) or 50μM amyloid-β protein fragment 25–35
(Sigma, A4559). For pharmacological inhibition of p97 function,
SH-SY5Y cells were treated with the p97-inhibitor DBeQ (Sigma,
SML0031) at 2.5μM for 20 h before further analysis (Chou et al.,
2011).
FLOW CYTOMETRY
Flow cytometry was performed using a CyAn ADP Analyzer
(Beckman Coulter). SH-SY5Y cells grown in 6 well cell culture
plates (Sarstedt) and induced and/or treated as indicated were
co-stained with DAPI and either 10 nM TMRE (Invitrogen) for
30min at 37◦C, or 5μM MitoSOX™ (Invitrogen) for 10min at
37◦C. Cells were harvested, washed twice in PBS and resuspended
in 1ml PBS containing 0.5% (w/v) BSA and 50μM EDTA. Flow
cytometry was performed immediately afterwards. Data analysis
was performed using FlowJo v.10. Sequential gating was per-
formed as follows (with identical gates used for each experiment):
cells were gated for using logarithmic forward/sideward scatter
axes; doublet discrimination was performed using forward scat-
ter area/forward scatter followed by pulse width/forward scatter
dot plots. Dead cells were excluded in DAPI/forward scatter
dot plots.
ISOLATION OF MITOCHONDRIA
The human mitochondria isolation kit (Miltenyi Biotec, 130-
094-532) was used according to manufacturer’s instructions.
Briefly, cells were harvested and either directly processed or stored
overnight in liquid nitrogen. All following steps were performed
on ice with pre-cooled buffers. Cells were resuspended in 800μl
lysis buffer supplemented with protease inhibitors (1μg/ml pep-
statin; 1μg/ml leupeptin; 1mM PMSF) and 50μM EDTA. Cells
were passed 15 times through a 25 gage needle. Nine milliliter
separation buffer and 50μl Anti-TOMM22 MicroBeads were
added to the cell homogenate before rotating the suspensions for
1 h at 4◦C. Magnetic separation was performed using a MACS
Separator. Purified mitochondria were immediately lysed in RIPA
buffer (Thermo Scientific) supplemented with protease inhibitors
(1μg/ml pepstatin; 1μg/ml leupeptin; 1mM PMSF) and 50μM
EDTA and subjected to five 10 s intervals of sonication at 10 kHz.
Total protein content was measured using the Pierce BCA protein
assay kit (Thermo Scientific) and was immediately followed by
DNPH labeling.
LABELING WITH DNPH
Labeling with DNPH was performed according to Wehr and
Levine (2013) with minor alterations. Briefly, 60μg of total pro-
tein in 20μl total volume was added to 20μl 12% sodium dodecyl
sulfate (SDS). 40μl of 20mM DNPH in 2M HCl were added,
samples were briefly mixed and incubated for 15min. To control
for DNPH-reactive protein carbonyls, samples were reacted with
2MHCl lacking DNPH. 30μl of 2MTris base, 30% glycerol and a
final concentration of 50mM 1,4-Dithiothreit were added to stop
the reaction. Samples were briefly mixed again and immediately
used for SDS PAGE.
WESTERN BLOT
DNPH-labeled protein lysates were resolved by SDS PAGE (5μg
total protein per lane were loaded) and blotted onto nitrocel-
lulose membrane (Whatman). Fast Green FCF (Sigma Aldrich,
F7252) was used to evaluate total protein loaded per lane as fol-
lows: nitrocellulose membranes were stained for 10min in Fast
Green FCF staining solution (0.001% FCF, 30% methanol, 7%
acetic acid), followed by 10min in destaining solution (30%
methanol, 7% acetic acid) and then 10min in water. An infrared
laser scanner (LiCor) was used for detection of FCF. Following
Fast Green FCF, membranes were blocked for 1 h in 3% (w/v)
Top Block (Lubio science, TB232010) in PBS-Tween 20 (0.05%)
and immune-detection using polyclonal rabbit anti-DNP anti-
bodies (D9656 Sigma, 1:2000) and polyclonal goat anti-rabbit
Dylight 800 (35521 Pierce, 1:6000) was performed and detected
using an infrared laser scanner (LiCor) to obtain quantita-
tive measurement. Each experiment was performed three times
independently and each measurement was performed in trip-
licates. Image analysis was performed using ImageJ (Schneider
et al., 2012). For the analysis of mitochondrial fractions by
western blotting mouse anti-p97 (10R-P104a Fitzgerald, 1:1000),
mouse anti-cytochrome c (556433 Pharmingen, 1:2000), and
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rabbit anti-calnexin (ab75801 abcam, 1:2000) were used and
detected using anti-mouse HRP or anti-rabbit HRP (Thermo
Scientific) and ECL Plus chemiluminescent reagent (1896327
Thermo Scientific).
MICROCOPY
Cells were seeded in 6-well plates onto glass slides at 1 × 104
cells/well in 2ml culture medium. Samples were fixed using
methanol-free electron microscopy grade 4% paraformaldehyde
in PBS for 15min at RT, permeabilized for 15min at RT using
0.15% Trixon X-100 in PBS and blocked for 1 h in 10% BSA (w/v)
in PBS. To visualize mitochondria, samples were then incubated
with mouse anti-cytochrome c antibody (BD Biosciences 556432,
1:1000) overnight at 4◦C and Alexa546-conjugated anti-mouse
antibodies (Invitrogen A11003, 1:500) for 1 h at RT. Nuclei were
stained by incubation with DAPI (Invitrogen, D1306, 1:1000) for
5min right after Alexa546 incubation. Samples were mounted
in mounting medium (Vectashield, H1000) and observed using
a confocal microscope (Zeiss LSM Meta710, 63 × / 1.4 objec-
tive). Mitochondria fragmentation and Parkin-to-mitochondria
translocation were assessed visually and quantified as percent-
age of control. The extend of mitochondrial fragmentation was
judged based on comparison to untreated control cells with
mitochondrial networks scored as fragmented if most mitochon-
dria in a cell did no longer exhibit an elongated phenotype. All
experiments were performed independently in triplicates.
STATISTICAL ANALYSIS
Statistical significance of differences was assessed using pair-wise
t-tests with the adjustment for multiple comparisons according to
Holmes as implemented in R (R Core Team, 2013). Significance is
indicated with n.s. p > 0.05, ∗ for p < 0.05, ∗∗ for p < 0.01, and
∗∗∗ for p < 0.001.
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